New VA study finds Paxlovid may cut the risk of long COVID
It's well-documented that Paxlovid - a 5-day course of antiviral pills from Pfizer - can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop seve…
It's well-documented that Paxlovid - a 5-day course of antiviral pills from Pfizer - can reduce the risk of hospitalization in COVID-19 patients who are more likely to develop seve…